Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Journal of Neurogenetics|January 27, 2009
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymesRiju Ray, Rachel F Tyndale, Caryn LermanAnnual Review of Medicine|July 28, 2009
Nicotine dependence: biology, behavior, and treatmentRiju Ray, Robert A Schnoll, Caryn LermanCNS Drugs|June 21, 2007
Pharmacogenetics and smoking cessation with nicotine replacement therapyRiju Ray, Robert A Schnoll, Caryn LermanDrug and Alcohol Dependence|May 19, 2012
Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility studyRebecca L Ashare, Riju Ray, Caryn Lerman, et al.Cancer Letters|May 27, 2005
Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinomaNeetu Sud, Rinu Sharma, Riju Ray, et al.NPJ Primary Care Respiratory Medicine|August 29, 2018
Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPDMeiLan K Han, Riju Ray, Jason Foo, et al.Pulmonary Pharmacology & Therapeutics|May 17, 2019
Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trialsRiju Ray, Lee Tombs, Ian Naya, et al.Expert Review of Vaccines|December 8, 2015
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccinesRafik Bekkat-Berkani, Riju Ray, Varsha K Jain, et al.The Pharmacogenomics Journal|March 19, 2008
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatmentD F Heitjan, D A Asch, Riju Ray, et al.Pulmonary Therapy|February 7, 2020
Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey StudyBeth Hahn, Richard H Stanford, Alyssa Goolsby Hunter, et al.Pageof 5